John P. Kelley, Director at ACORDA THERAPEUTICS INC (ACOR), sold 15,000 shares at $38.00 ($570K) on 2013-08-02, disclosed to the SEC on 2013-08-06.
Scheduled sale ($570k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MDCO | BUY | 2007-08-07 | $46K | — | Filing → |
| MDCO | SELL | 2007-01-05 | $1.6M | — | Filing → |